Net profit of Emcure Pharmaceuticals rose 64.07% to Rs 188.96 crore in the quarter ended March 2025 as against Rs 115.17 crore during the previous quarter ended March 2024. Sales rose 19.47% to Rs 2116.25 crore in the quarter ended March 2025 as against Rs 1771.36 crore during the previous quarter ended March 2024.
For the full year,net profit rose 36.76% to Rs 681.33 crore in the year ended March 2025 as against Rs 498.18 crore during the previous year ended March 2024. Sales rose 18.59% to Rs 7896.00 crore in the year ended March 2025 as against Rs 6658.25 crore during the previous year ended March 2024.
| Particulars | Quarter Ended | Year Ended |
| Mar. 2025 | Mar. 2024 | % Var. | Mar. 2025 | Mar. 2024 | % Var. |
| Sales | 2116.25 | 1771.36 | 19 | 7896.00 | 6658.25 | 19 |
| OPM % | 19.02 | 17.58 | - | 18.67 | 18.47 | - |
| PBDT | 367.83 | 257.61 | 43 | 1365.86 | 1049.57 | 30 |
| PBT | 270.99 | 167.04 | 62 | 981.73 | 737.16 | 33 |
| NP | 188.96 | 115.17 | 64 | 681.33 | 498.18 | 37 |